Aura Biosciences (AURA) Change in Account Payables (2020 - 2026)
Aura Biosciences' (AURA) quarterly Change in Account Payables came in at $1.0 million in Q1 2026, up 443.62% YoY from $188365.4 in Q1 2025, and up 338.14% on a QoQ basis from -$430000.0 in Q4 2025.
Aura Biosciences (AURA) Change in Account Payables (2020 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Change in Account Payables data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Change in Account Payables rose 443.62% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $476000.0 (up 195.65% YoY) and the FY2025 annual result came in at -$846000.0, down 275.52% from the prior year.
- Change in Account Payables rose to $1.0 million in Q1 2026, from -$430000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.0 million in Q1 2026 to a low of -$1.9 million in Q1 2023.
- A 5-year average of -$2352.9 and a median of $23000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 524.54% — and 2025, when it plunged 1395.65%.
- Tracing AURA's Change in Account Payables over 5 years: stood at $1.0 million in 2022, then slumped by 55.11% to $457000.0 in 2023, then sank by 32.17% to $310000.0 in 2024, then tumbled by 238.71% to -$430000.0 in 2025, then soared by 338.14% to $1.0 million in 2026.
- The last three Change in Account Payables figures came in at $1.0 million (Q1 2026), -$430000.0 (Q4 2025), and $602000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - | -326,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -326,000.00 |
| Jun 30, 2026 | -326,000.00 |
| Mar 31, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | -430,000.00 |
| Dec 31, 2025 | -430,000.00 |
| Sep 30, 2025 | 602,000.00 |
| Sep 30, 2025 | 602,000.00 |
| Jun 30, 2025 | -720,000.00 |
| Jun 30, 2025 | -720,000.00 |
| Mar 31, 2025 | -298,000.00 |
| Mar 31, 2025 | -298,000.00 |
| Dec 31, 2024 | 310,000.00 |
| Dec 31, 2024 | 310,000.00 |
| Sep 30, 2024 | 689,000.00 |
| Sep 30, 2024 | 689,000.00 |
| Jun 30, 2024 | -540,000.00 |
| Jun 30, 2024 | -540,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |